UroGen Pharma Ltd.
URGN · Healthcare · $2.0B
$40.63+0.44%
Price
$38.02
$40.45
Jul 2, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue$72M+42.2%
Operating Income$0MTurned profitable
Net Income-$14M+39.1%
3/'26 vs prev quarter
Company Health
Market Cap$2.0B
Operating Margin-35.3%
Cash on Hand$108M5.5% of market cap
Free Cash Flow$-205M-10.3% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR10.5xmedian 11.4xROE+73.8%median -54.5%
